Concepedia

Stephanie Wernick

SW

2

Publications

69

Citations

2

H-Index

2019

Active since

Affiliations

Max Planck Institute of Experimental Medicine(Current)

Universitätsmedizin Göttingen

Pharnext (France)

Stephanie Wernick is an author at Max Planck Institute of Experimental Medicine specializing in gene therapies, cell biology, and neurology.

Top concepts

Publications per year

2019–2020

2

Publications

2

Early short-term PXT3003 combinational therapy delays disease onset in a transgenic rat model of Charcot-Marie-Tooth disease 1A (CMT1A)

Thomas Prukop, Jan Stenzel, Stephanie Wernick et al. · PLoS ONE · 2019 · 48 citations · Full text

, , +15

Synergistic PXT3003 therapy uncouples neuromuscular function from dysmyelination in male Charcot–Marie–Tooth disease type 1A (CMT1A) rats

Thomas Prukop, Stephanie Wernick, Lydie Boussicault et al. · Journal of Neuroscience Research · 2020 · 21 citations · Full text

Rows per page

1–2 of 2